Prerequisites for human papillomavirus vaccine trial: results of feasibility studies.

[1]  M. Lehtinen,et al.  Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination , 2000, Sexually transmitted infections.

[2]  M. Hakama,et al.  Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963–1995: Recent increase in cervical cancer incidence , 1999, International journal of cancer.

[3]  M. Sapp,et al.  Prospective study on cervical neoplasia IV. Presence of HPV antibodies , 1999, International journal of cancer.

[4]  M. Lehtinen,et al.  Stability over time of serum antibody levels to human papillomavirus type 16. , 1998, The Journal of infectious diseases.

[5]  R. Burk,et al.  Natural history of cervicovaginal papillomavirus infection in young women , 1998 .

[6]  T. Bjørge,et al.  Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. , 1997, Journal of the National Cancer Institute.

[7]  K. Shah,et al.  Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  C. Wheeler,et al.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective , 1997, Journal of virology.

[9]  M. Lehtinen,et al.  Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction , 1996, Cancer.

[10]  R. Peto,et al.  Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study , 1996, BMJ.

[11]  M. Evander,et al.  Human Papillomavirus Infection Is Transient in Young Women: A PopulationBased Cohort Study , 1995 .

[12]  V. Kataja,et al.  Prevalence, Incidence, and Estimated Life‐time Risk of Cervical Human Papillomavirus Infections in a Nonselected Finnish Female Population , 1990, Sexually transmitted diseases.